🇲🇾 NPRA — Pusat Kawalan Kualiti · ISO/IEC 17025 Accredited

◈ Seksyen Pengujian Produk & Kosmetik · Unit Penyaringan

PKKK/300/UP/030 Identifikasi dan Kandungan Menthol, Camphor, Methyl Salicylate dan Thymol dalam produk tradisional menggunakan GCMS

Arahan Kerja Rasmi (Level 300 SOP) · Kategori: GC-MS
1
1. Reagen & Piawai
Penyediaan fasa bergerak, stok & kalibrasi
2
2. Pengekstrakan
Timbang, sonikasi, sentrifug & turas 0.45µm
3
3. Persediaan Alat
Purging saluran, autotune & baseline
4
4. Suntikan Batch
Blank, SST (n=6), Sampel & IQC
5
5. Verifikasi & Rekod
Padanan RT, spektrum UV/MS & Laporan
Spesifikasi & Parameter Kromatografi / Analitikal (Official Parameters):
Instrumen UtamaAgilent 8890 / Shimadzu QP2010 GC-MS
Turus / ColumnBP-624 (30 m × 0.25 mm × 1.4 µm)
Fasa Bergerak / PelarutHelium Gas Pembawa (Linear Velocity: 48.5 cm/sec)
Kadar Alir & Suhu1.70 mL/min (Split 30:1 @ 230 °C) @ Oven: 60 °C (1 min) → 10 °C/min ke 220 °C (2 min)
Pengesan / Gelombang / SIMMS EI 70 eV · Scan m/z 35 – 350 amu
Kriteria Kesesuaian Sistem (SST)SST %RSD ≤ 5.0% bagi Menthol, Camphor, Methyl Salicylate, kalibrasi R² ≥ 0.995.
🎯 Sebatian Sasaran Pengujian:
MentholCamphorMethyl SalicylateThymol
💡 Petua & Perhatian Penting Makmal (Bench Notes):
Analyst Benchtop Checklist Progress
0 / 63 Langkah Selesai (0%)
NPRA
PUSAT KAWALAN KUALITI
ARAHAN KERJA: IDENTIFIKASI DAN KANDUNGAN MENTHOL, CAMPHOR, METHYL SALICYLATE DAN THYMOL DALAM PRODUK TRADISIONAL MENGGUNAKAN GCMS
No. Dokumen: PKKK/300/UP/030 Terbitan / Semakan: Terbitan 3 Semakan 0
Tarikh Kuatkuasa: 10 April 2026 Bahagian / Unit: SPPK · Unit Penyaringan
📋

0.0 SEJARAH PINDAAN & SEMAKAN

📋 Sejarah Pindaan & Semakan Dokumen (8 entri)

Terbitan 1, Semakan 1:

Menambah perenggan 6.4.5 Internal Quality Control

Mengemaskini perenggan 5.4, penolong pegawai farmasi ditukar daripada U36 / U32 kepada U7 / U6

Mengemaskini perenggan 3 Definisi

Mengemaskini perenggan 6.4.2 Table for Sequence of Injection

Mengemaskini perenggan 6.3.1 vi, 6.3.2 ii dan 6.4.2

Mengemaskini perenggan 6.5 vii dengan menambah “IQC table”

Terbitan 2, Semakan 0:

PKKK/300/UAT/001 kepada PKKK/300/UP/001;

PKKK/300/UAT/011 kepada PKKK/300/UP/010;

iii. Mengemasikini 6.4.1 Gas chromatographic and MS Condition dengan penambahan Column Dimension pada Table 3. GCMS system for identification and assay of menthol, camphor, methyl salicylate and thymol.

iv. Mengemaskini Table 5: SIM mode for identification and assay of menthol, camphor, methyl salicylate, and thymol dengan penambahan “Remarks: The data acquisition time windows will be adjusted according to the observed retention times of target analytes to ensure comprehensive peak capture and optimal instrumental efficiency”.

v. Mengemaskini para 7 Rekod Kualiti dengan menambah:

UP/001A Borang Persampelan

UP/007 Laporan Pengujian Identifikasi dan Kandungan Menthol, Camphor,

Methyl Salicylate dan Thymol dalam Produk Tradisional Menggunakan GCMS

🎯

1.0 TUJUAN

Untuk memastikan ujian identifikasi dan kandungan Menthol, Camphor, Methyl Salicylate dan Thymol dalam produk tradisional menggunakan Gas Chromatography-Mass Spectrometer (GCMS) dilaksanakan dengan cekap dan berkesan.

📐

2.0 SKOP

🔬

6.0 PROSEDUR

Instrument: Gas Chromatography Mass Spectrometer (GCMS)

Column: BP-624, 6% Cyanopropylphenyl 94% Dimethylpolysiloxane, with dimension of 30 m x 0.25 mm and particle size of 1.4 µm or equivalent.

Analytical balance and microbalance

Sonicator

Reference standard: Primary or secondary RS of equivalent.

Menthol

Camphor

Methyl Salicylate

Thymol

Eugenol

Chemical:

Methanol

Glassware and consumables:

Conical flask

Amber volumetric flask

Disposable syringe without needle, 5 ml

Nylon solvent filter, 0.45µm

Amber glass screw cap vial, 2 ml

Amber glass screw cap vial, 50 ml

Liquid form: Pipette 10 µl of eugenol reference standard into a 25 ml amber volumetric flask. Dissolve and dilute to volume with methanol. Filter the solution through a 0.45 µm nylon syringe filter into an amber vial.

Powder form: Weigh 10 mg of eugenol reference standard into a 25 ml amber volumetric flask. Dissolve and dilute to volume with methanol. Filter the solution through a 0.45 µm nylon syringe filter into an amber vial.

For methyl salicylate: Pipette 7 µl of methyl salicylate into a 20 mL amber volumetric flask and repeat steps ii and iii.

Preparation of Mixed Working Standard Solution (0.1 mg/ml or 100 µg/ml).

Pipette 12.5 ml of each standard stock solution into an amber 50 ml vial.

Refer to the table below for preparation details:

Table 1: Preparation of mix working standard solution for calibration curve.

Option to prepare mix working standard solution for calibration in 5 mL volumetric flask. The preparation as in the table below:

Table 2: Preparation of mix working standard solution for calibration curve.

For system suitability test (SST), use the Level 3 concentration (20 µg/ml of each compound) as the system suitability solution.

Pipette 50 µl of mixed working standard solution into 5 ml volumetric flask and add 1000 µl of internal standard (IS) solution.

Use the Level 1 concentration (3 µg/ml of each compound) as the LOQ solution.

Patch / Medicated Plaster

Cut the sample into small pieces.

Cool the solution to room temperature.

Sampling the sample according to PKKK/300/UP/001.

Cool the solution to room temperature.

Perform appropriate dilutions if the sample concentration exceeds the linear range of the calibration curve.

Document the step-by-step dilution preparation in the worksheet.

The GCMS system used for detection of menthol, camphor, methyl salicylate and thymol in traditional product are given in table 2 below.

Table 3: GCMS system for identification and assay of menthol, camphor, methyl salicylate and thymol

Table 4: Oven temperature program for identification and assay of menthol, camphor, methyl salicylate and thymol

Table 5: SIM mode for identification and assay of menthol, camphor, methyl salicylate, and thymol

(*) Remarks: The data acquisition time windows will be adjusted according to the observed retention times of target analytes to ensure comprehensive peak capture and optimal instrumental efficiency.

For each injection, a volume of 0.5 µl of the solution will be administered. The sequence of injection is shown in the table below.

Table 6: Sequence of injection for identification and assay of menthol, camphor, methyl salicylate and thymol

* After five samples are injected, the LOD solution will be injected before proceeding with the remaining samples.

The acceptance criteria for SST, LOD and LOQ are shown in the table below.

Table 7: Requirement for SST, LOD and LOQ of identification and assay of menthol, camphor, methyl salicylate and thymol

Standard injection and calibration curve

Generate a calibration curve by plotting concentration against area, and determine the linearity equation along with the correlation coefficient (R2).

This step (ii) can be performed using the instrument’s software (GCMSsolution).

Ensure that the correlation coefficient (R²) is equal to or greater than 0.995. If the correlation does not meet this requirement, re-inject the working standard solution until the desired criteria are met.

Acceptance criteria for Internal Quality Control Check (IQC):

The percentage difference of retention time for LOD solution should not be more than 3 % for every batch of 5 samples.

Identification

The identification of the target compound is considered positive when the following criteria are met:

Retention time

The retention time of the target compound in the sample chromatogram corresponds to the retention time in the chromatogram of the working standard.

Mass Spectrum Confirmation

Confirmation is based on the detection of the target ion and reference ions.

Reference ions are monitored as relative ion intensity, with the maximum permissible tolerance defined in Table 8:

Table 8: Tolerance for reference ion intensity for identification of menthol, camphor, methyl salicylate and thymol

Reporting Results

NOT DETECTED: The compound is reported as NOT DETECTED when the peak area ratio of the compound to the internal standard (IS) in the sample solution is below the peak area ratio of the standard solution at the limit of detection (LOD, 1 µg/mL).

BELOW QUANTITATION LIMIT: The compound is reported as BELOW QUANTITATION LIMIT (3 µg/mL) when the peak area ratio of the compound to IS in the sample solution is below the peak area ratio of the standard solution at the limit of quantitation (LOQ, 3 µg/mL)

Quantifiable Amounts: If the peak area ratio of the compound to IS in the sample solution exceeds the peak area ratio of the standard solution at the LOQ level, the compound's concentration must be calculated using the calibration curve extrapolation as outlined in section B. Assay.

Assay

The amounts of menthol, camphor, methyl salicylate, and thymol are determined using the extrapolation of the calibration curve.

Therefore, the final amount of each compound in the sample is calculated and reported as percent weight / weight (% w/w).

This calculation in step (ii), is performed using the following formula:

Equation 1: Calculation for the amount of menthol, camphor, methyl salicylate and thymol

Limits or specifications

Menthol and Camphor

The limits for menthol and camphor are defined according to the Drug Registration Guidance Document (DRGD), Third Edition, Eight Revision, July 2024.

The limits are outlined in Table 9:

Table 9: Limits or specifications for the assay of menthol and camphor

Methyl Salicylate and Thymol

The DRGD does not specify limits or guidelines for methyl salicylate and thymol.

If the amounts of these compounds need to be reported, they will be presented as the measured values.

Each sample must have a dedicated analysis report, which includes the following details:

Sample Details

Sample name

Sample number

Batch number

Analysis Date

Equipment Parameters

Equipment name

Gas chromatographic (GC) conditions

Mass spectrometry (MS) conditions.

Reference Standard (RS)

List of RS used in the analysis

Preparation procedure for RS, including printed RS weight

Sample Preparation

Sample preparation procedure

Printed sample weight (duplicate weighing)

Interpretation of Results

Detailed interpretation based on criteria outlined in the SOP

Evidence of Analysis

Evidence must be attached to the analysis report, including:

Compilation of chromatograms for calibration curve solutions

Chromatogram for LOD and LOQ solutions

Chromatogram of working standard (first injection of SST)

Compilation of chromatograms for SST

Chromatogram for blank solution prior to and after the sample solution injection

Chromatograms for samples A and B

IQC table

📖

3.0 DEFINISI

🔀

4.0 CARTA ALIRAN

Tiada carta aliran untuk prosedur ini.

👥

5.0 TANGGUNGJAWAB

Memastikan prosedur ini dipatuhi semasa pengujian dijalankan.

Menyemak dan mengesahkan semua laporan ujian tidak lulus yang telah disemak oleh Pegawai Farmasi termasuk laporan OOS.

Ketua Unit / Pegawai Farmasi Bertanggungjawab

Mengagih sampel kepada Pegawai Farmasi.

Memastikan prosedur ini dipatuhi semasa pengujian dijalankan.

Menyemak dan mengesahkan semua laporan ujian yang telah disemak oleh Pegawai Farmasi termasuk laporan OOS.

Mengagihkan sampel kepada Pegawai Farmasi dan Penolong Pegawai Farmasi.

Menyelia ujian yang dijalankan oleh Pegawai Farmasi dan Penolong Pegawai Farmasi.

Menyemak laporan ujian.

Menjalankan siasatan OOS dan menyediakan laporan OOS bagi sampel gagal ujian.

Menjalankan aktiviti pengujian sampel mengikut tatacara yang telah ditetapkan.

Penolong Pegawai Farmasi U7 / U6

Mengambil dan merekodkan penerimaan sampel dari Unit Perkhidmatan Analisis (UPA)

Merekodkan bilangan ujian selepas selesai laporan ujian disiapkan untuk tujuan laporan bulanan.

Menghantar laporan ujian ke UPA untuk simpanan.

Menjalankan aktiviti pengujian sampel mengikut tatacara yang telah ditetapkan.

Menyediakan laporan ujian.

📝

7.0 REKOD KUALITI

No. Borang Tajuk

UP/001A Borang Persampelan

UP/007 Laporan Pengujian Identifikasi dan Kandungan Menthol, Camphor,

Methyl Salicylate dan Thymol dalam Produk Tradisional

Menggunakan GCMS

📊

Jadual Kromatografi & Rujukan Data

SEJARAH SEMAKAN PKKK/300/UP/030
TerbitanSemakanDitulis OlehDisemak OlehDiluluskan OlehTarikh Kuatkuasa
10Nurul ‘Izzah Hany IsmailOoi Suat HongIda Syazrina Ibrahim17 Feb 2025
11Nurul ‘Izzah Hany IsmailOoi Suat HongIda Syazrina Ibrahim1 Julai 2025
20Nurul ‘Izzah Hany IsmailNurul Nadiah NohIda Syazrina Ibrahim10 April 2026
JADUAL 2 PKKK/300/UP/030
RUJUKANRUJUKAN
No. DokumenTajuk
PKKK/300/UAT/001Proses persampelan (Ujian Penyaringan)
PKKK/300/UAT/010Gas Chromatography Mass Spectrometer Shimadzu (QP2010 Ultra)
Drug Registration Guidance Document (DRGD), 3rd Edition, Eight Revision July 2024. (Appendix 7)
Drug Registration Guidance Document (DRGD), 3rd Edition, Eight Revision July 2024. (Appendix 18)
JADUAL 3 PKKK/300/UP/030
LevelMixed Standard Stock (µl)IS Stock (µl)Methanol (µl)Concentration of each compound (µg/ml)Concentration of IS (µg/ml)
1 (LOQ)453001155380
215030010501080
33003009002080
46003006004080
51200300-8080
JADUAL 4 PKKK/300/UP/030
LevelMixed Standard Stock (µL)IS Stock (µL)Make up to volume with Methanol, mLConcentration of each compound (µg/mL)Concentration of IS (µg/mL)
115010005380
2500100051080
31000100052080
42000100054080
54000100058080
JADUAL 5 PKKK/300/UP/030
GC ParametersGC Parameters
ColumnBP-624, 6% Cyanopropylphenyl 94% Dimethylpolysiloxane
Column Dimension30 m x 0.25 mm x 1.4 µm
Oven temperatureRefer table 4
Flow control modeLinear Velocity (48.5 cm/sec)
Flow rate1.70 ml/min
GasHelium (Purity: 99.999%)
Injection modeSplit (30:1)
Injector temperature230°C
Injection volume0.5 µL
MS ParametersMS Parameters
Interface temperature230°C
EI ion source / MS source temperature200°C
EI ionization energy70 eV
Solvent delayScan off: 0 to 3.00 minutes due to solvent peak (methanol)
Scan rangem/z 50 to m/z 200
SIM ionsRefer table 5
JADUAL 6 PKKK/300/UP/030
Oven rampRate (°C/min)Final temperature (°C)Hold time (minute)Run time (minute)
Initial1000.0
Ramp 151700.0
Post run402005.019.75
JADUAL 7 PKKK/300/UP/030
CompoundAcquisition time (minute) (*)SIM IonsTest
Camphor9.00 – 11.001. Target; m/z 108.15Quantitation
Camphor9.00 – 11.002. Reference 1: m/z 83.10 3. Reference 2: m/z 79.05Qualification
Menthol9.00 – 11.001. Target; m/z 71.05Quantitation
Menthol9.00 – 11.002. Reference 1: m/z 57.05 3. Reference 2: m/z 123.05Qualification
Methyl salicylate11.00 – 13.001. Target; m/z 120.05Quantitation
Methyl salicylate11.00 – 13.002. Reference 1: m/z 152.10 3. Reference 2: m/z 92.00Qualification
Thymol13.00 – 18.001. Target; m/z 135.10Quantitation
Thymol13.00 – 18.002. Reference 1: m/z 150.15 3. Reference 2: m/z 91.05Qualification
Eugenol13.00 – 18.001. Target; m/z 164.10Quantitation
Eugenol13.00 – 18.002. Reference 1: m/z 149.10 3. Reference 2: m/z 131.10Qualification
JADUAL 8 PKKK/300/UP/030
No. of sequenceDetailsTotal of injection
1Blank solution (methanol)1
2LOD solution1
3 – 7Calibration curve solution (Level 1 – 5)1 (each level)
8Blank solution (methanol)1
9 – 14System suitability solution6
15Blank solution (methanol)1
16Sample 1 (Replicate A)1
17Sample 1 (Replicate B)1
18Blank solution (methanol)1
19Sample 2 (Replicate A)1
20Sample 2 (Replicate B)1
21Blank solution (methanol)1
22LOD solution1
JADUAL 9 PKKK/300/UP/030
ParameterAcceptance criteria
Tailing factor, TfNMT 2.0
Theoretical plate, NNLT 2000
% RSD (peak area ratio) for 6 injections of working standard solution at Level 3.NMT 5.0 %
S/N ratio of LOD solution (1 µg/ml)NLT 3
S/N ratio of LOQ solution (3 µg/ml)NLT 10
JADUAL 10 PKKK/300/UP/030
Relative ion intensity (% of base peak)Tolerance (%)
> 50± 10
20 – 50± 15
10 - 20± 20
JADUAL 11 PKKK/300/UP/030
Amount of each compound=Measured Concentration from GCMS (µg/mL)xTotal volume sample solution (mL)xDilution Factor (if any)xPurity (%)x1
(% w/w)=Measured Concentration from GCMS (µg/mL)xWeight of Sample Taken (g)xDilution Factor (if any)xPurity (%)x10000
JADUAL 12 PKKK/300/UP/030
CompoundRestricted LimitReference
MentholFor external preparations: NMT 10% (active ingredients)Appendix 18: List of Permitted, Prohibited and Restricted Substances
MentholFor external preparations: NMT 10% (excipients)Appendix 7: Guideline on Registration of Natural Products
CamphorFor external preparations: NMT 11%Appendix 18: List of Permitted, Prohibited and Restricted Substances